Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Impact of Atogepant on Patient Functioning Among Participants With Episodic Migraine: Migraine-Specific Quality of Life Questionnaire v2.1 Item-Level Analysis

              Author:Lipton, Richard   Gandhi, Pranav   Buse, Dawn   Matharu, Manjit   Carr, Karen   Dabruzzo, Brett   Liu, Yingyi   Stokes, Jonathan   Pozo-Rosich, Patricia   

              Session Name:P8: Headache: Advances in CGRP Inhibition 2  

              Topic:Headache  

              Program Number:P8.002  

              Author Institution:Albert Einstein College of Medicine, Bronx, NY  AbbVie, Madison, NJ  Albert Einstein College of Medicine, San Diego, CA  University College London, London, United Kingdom  AbbVie, Mettawa, IL  AbbVie, Frederick, MD  AbbVie, North Chicago, IL  Universitat Autonoma of Barcelona, Barcelona, Spain  

              Change in Migraine Based on a Patient Global Impression of Change in Participants with Episodic Migraine and Chronic Migraine: Results from 5 Atogepant Clinical Trials

              Author:Goadsby, Peter   Gandhi, Pranav   Sacco, Simona   Rhyne, Christopher   Bilchik, Tanya   Carr, Karen   Chalermpalanupap, Natty   Stokes, Jonathan   Dabruzzo, Brett   Tepper, Stewart   

              Session Name:P8: Headache: Advances in CGRP Inhibition 2  

              Topic:Headache  

              Program Number:P8.006  

              Author Institution:Kings College London  University of California, Los Angeles, Los Angeles, CA  AbbVie, Madison, NJ  University of L'Aquila, L'Aquila, Italy  Diamond Headache Clinic, Chicago, IL  Yale University Department of Neurology , New Haven , CT  AbbVie, Mettawa, IL  AbbVie, Frederick, MD  The New England Institute for Neurology and Headache, Stamford, CT